Plastic deformation of highly alloyed austenitic transformation‐induced plasticity (TRIP) steels with low stacking fault energy leads typically to the formation of ɛ‐martensite within the original austenite. The ɛ‐martensite is often described as a phase having a hexagonal close‐packed crystal structure. In this contribution, an alternative structure model is presented that describes ɛ‐martensite embedded in the austenitic matrix via clustering of stacking faults in austenite. The applicability of the model was tested on experimental X‐ray diffraction data measured on a CrMnNi TRIP steel after 15% compression. The model of clustered stacking faults was implemented in the DIFFaX routine; the faulted austenite and ɛ‐martensite were represented by different stacking fault arrangements. The probabilities of the respective stacking fault arrangements were obtained from fitting the simulated X‐ray diffraction patterns to the experimental data. The reliability of the model was proven by scanning and transmission electron microscopy. For visualization of the clusters of stacking faults, the scanning electron microscopy employed electron channelling contrast imaging and electron backscatter diffraction.

In this work the physico-chemical properties of selected cryoprotectants (antifreeze protein TrxA-AFP752, trehalose and dimethyl sulfoxide) were correlated with their impact on the constitution of ice and influence on frozen/thawed cell viability. The freezing processes and states of investigated materials solutions were described and explained from a fundamental point of view using ab-initio modelling (molecular dynamics, DFT), Raman spectroscopy, Differential Scanning Calorimetry and X-Ray Diffraction. For the first time, in this work we correlated the microscopic view (modelling) with the description of the frozen solution states and put these results in the context of human skin fibroblast viability after freezing and thawing. DMSO and AFP had different impacts on their solution's freezing process but in both cases the ice crystallinity size was considerably reduced. DMSO and AFP treatment in different ways improved the viability of frozen/thawed cells.

In this work, we shed new light on the highly debated issue of chromatin fragmentation in cryopreserved cells. Moreover, for the first time, we describe replicating cell-specific DNA damage and higher-order chromatin alterations after freezing and thawing. We identified DNA structural changes associated with the freeze-thaw process and correlated them with the viability of frozen and thawed cells. We simultaneously evaluated DNA defects and the higher-order chromatin structure of frozen and thawed cells with and without cryoprotectant treatment. We found that in replicating (S phase) cells, DNA was preferentially damaged by replication fork collapse, potentially leading to DNA double strand breaks (DSBs), which represent an important source of both genome instability and defects in epigenome maintenance. This induction of DNA defects by the freeze-thaw process was not prevented by any cryoprotectant studied. Both in replicating and non-replicating cells, freezing and thawing altered the chromatin structure in a cryoprotectant-dependent manner. Interestingly, cells with condensed chromatin, which was strongly stimulated by dimethyl sulfoxide (DMSO) prior to freezing had the highest rate of survival after thawing. Our results will facilitate the design of compounds and procedures to decrease injury to cryopreserved cells.

No abstract